These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15835077)

  • 1. Immunology of intraocular tumors.
    Niederkorn JY; Wang S
    Ocul Immunol Inflamm; 2005 Feb; 13(1):105-10. PubMed ID: 15835077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune escape mechanisms of intraocular tumors.
    Niederkorn JY
    Prog Retin Eye Res; 2009 Sep; 28(5):329-47. PubMed ID: 19563908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an Immunogenic Subset of Metastatic Uveal Melanoma.
    Rothermel LD; Sabesan AC; Stephens DJ; Chandran SS; Paria BC; Srivastava AK; Somerville R; Wunderlich JR; Lee CC; Xi L; Pham TH; Raffeld M; Jailwala P; Kasoji M; Kammula US
    Clin Cancer Res; 2016 May; 22(9):2237-49. PubMed ID: 26712692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulation of intraocular tumours.
    Niederkorn JY
    Eye (Lond); 1997; 11 ( Pt 2)():249-54. PubMed ID: 9349421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma.
    Bronkhorst IH; Vu TH; Jordanova ES; Luyten GP; Burg SH; Jager MJ
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5370-8. PubMed ID: 22743317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digital PCR-Based T-cell Quantification-Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma.
    de Lange MJ; Nell RJ; Lalai RN; Versluis M; Jordanova ES; Luyten GPM; Jager MJ; van der Burg SH; Zoutman WH; van Hall T; van der Velden PA
    Mol Cancer Res; 2018 Dec; 16(12):1902-1911. PubMed ID: 30093564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
    Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
    Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA expression and tumor-infiltrating immune cells in uveal melanoma.
    de Waard-Siebinga I; Hilders CG; Hansen BE; van Delft JL; Jager MJ
    Graefes Arch Clin Exp Ophthalmol; 1996 Jan; 234(1):34-42. PubMed ID: 8750848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells.
    Repp AC; Mayhew ES; Apte S; Niederkorn JY
    J Immunol; 2000 Jul; 165(2):710-5. PubMed ID: 10878343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of tumor-infiltrating lymphocytes in the treatment of hepatic metastases arising from transgenic intraocular tumors in mice.
    Ma D; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1067-75. PubMed ID: 7730016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma.
    Tavera RJ; Forget MA; Kim YU; Sakellariou-Thompson D; Creasy CA; Bhatta A; Fulbright OJ; Ramachandran R; Thorsen ST; Flores E; Wahl A; Gonzalez AM; Toth C; Wardell S; Mansaray R; Radvanyi LG; Gombos DS; Patel SP; Hwu P; Amaria RN; Bernatchez C; Haymaker C
    J Immunother; 2018; 41(9):399-405. PubMed ID: 29757889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive T cell immunotherapy of human uveal melanoma targeting gp100.
    Sutmuller RP; Schurmans LR; van Duivenvoorde LM; Tine JA; van Der Voort EI; Toes RE; Melief CJ; Jager MJ; Offringa R
    J Immunol; 2000 Dec; 165(12):7308-15. PubMed ID: 11120866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophages in uveal melanoma and in experimental ocular tumor models: Friends or foes?
    Jager MJ; Ly LV; El Filali M; Madigan MC
    Prog Retin Eye Res; 2011 Mar; 30(2):129-46. PubMed ID: 21129496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory cell infiltrates in advanced metastatic uveal melanoma.
    Krishna Y; McCarthy C; Kalirai H; Coupland SE
    Hum Pathol; 2017 Aug; 66():159-166. PubMed ID: 28655639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.
    Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma.
    Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1414-21. PubMed ID: 11381040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aqueous immune mediators in malignant uveal melanomas in comparison to benign pigmented intraocular tumors.
    Usui Y; Tsubota K; Agawa T; Ueda S; Umazume K; Okunuki Y; Kezuka T; Yamakawa N; Goto H
    Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):393-399. PubMed ID: 27878431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of uveal melanoma.
    Bosch JJ
    Dev Ophthalmol; 2012; 49():137-149. PubMed ID: 22042018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of Uveal Melanoma: Vaccination Against Cancer.
    Kummer M; Schuler-Thurner B
    Methods Mol Biol; 2017; 1499():273-278. PubMed ID: 27987156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominant expression of T cell receptor V alpha 7 in tumor-infiltrating lymphocytes of uveal melanoma.
    Nitta T; Oksenberg JR; Rao NA; Steinman L
    Science; 1990 Aug; 249(4969):672-4. PubMed ID: 2382141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.